Why should they buy their own crap? They know best what they have and what it's worth:
- A drug whose market is saturated, the patent is expiring, and competition is waiting in the wings
- A zinc paste for €140 that no one buys
- No pipeline
Would you, as a board member, buy back shares based on this "foundation"? Of course not. You would make sure the money stays in your account and continues to pay you a salary for the next few years until there's nothing left. It's that simple.
- Forums
- ASX - By Stock
- CUV
- Ann: Notification of buy-back - CUV
CUV
clinuvel pharmaceuticals limited
Add to My Watchlist
0.72%
!
$9.69

Ann: Notification of buy-back - CUV, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$9.69 |
Change
-0.070(0.72%) |
Mkt cap ! $489.2M |
Open | High | Low | Value | Volume |
$9.58 | $9.79 | $9.44 | $333.1K | 34.80K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 75 | $9.69 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.73 | 304 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 100 | 9.690 |
2 | 302 | 9.650 |
1 | 53 | 9.630 |
1 | 18 | 9.620 |
2 | 569 | 9.610 |
Price($) | Vol. | No. |
---|---|---|
9.730 | 118 | 4 |
9.740 | 111 | 2 |
9.750 | 100 | 2 |
9.760 | 132 | 3 |
9.770 | 135 | 2 |
Last trade - 10.09am 18/06/2025 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online